Related Experiment Video
Updated: Aug 13, 2026
06:38
Early Detection of Drug-Induced Renal Hemodynamic Dysfunction Using Sonographic Technology in Rats
Published on: March 11, 2016
[Renal dysfunction in workers exposed to arsenic and cadmium]
Feng Hong1, Tai-yi Jin, Guo-dong Lu
1Department of Occupational Health & Toxicology, School of Public Health, Fudan University, Shanghai 200032, China.
Summary
Combined exposure to arsenic and cadmium significantly worsens kidney injury in workers. This additive effect on renal dysfunction highlights the risks of co-exposure to these heavy metals.
Area of Science:
- Environmental toxicology
- Occupational health
- Renal toxicology
Context:
- Workers exposed to heavy metals like arsenic and cadmium face significant health risks.
- Assessing the combined nephrotoxic effects of these metals is crucial for occupational health surveillance.
- Biomarkers are essential for monitoring exposure and early detection of kidney damage.
Purpose:
- To investigate the synergistic or additive nephrotoxicity of combined arsenic and cadmium exposure in occupationally exposed individuals.
- To evaluate the relationship between urinary levels of arsenic and cadmium and biomarkers of kidney dysfunction.
- To determine if combined exposure leads to more severe renal injury compared to individual exposures.
Summary:
- Urinary cadmium and arsenic levels were measured as exposure biomarkers.
- Biomarkers of tubular and glomerular dysfunction, including urinary beta2-microglobulin (Ubeta2-MG), albumin (UALB), and N-acetyl-beta-D-glucosaminidase (UNAG), were assessed.
- Combined exposure to cadmium and arsenic resulted in more severe renal injury than exposure to either metal alone, with significant dose-effect relationships observed.
Impact:
- The findings suggest an additive effect of cadmium and arsenic on renal dysfunction in exposed workers.
- This study underscores the importance of monitoring co-exposure to arsenic and cadmium in occupational settings.
- Results provide critical data for developing targeted interventions to prevent heavy metal-induced kidney disease in vulnerable populations.
More Related Videos
09:23Removal of Trace Elements by Cupric Oxide Nanoparticles from Uranium In Situ Recovery Bleed Water and Its Effect on Cell Viability
Published on: June 21, 2015
06:32Development of Human Renal Tubular Epithelial Cell Primary Cultures in Monolayers and Three-Dimensional Conditions
Published on: June 13, 2025
Related Concept Videos
01:11Renal Failure: Dose Adjustments
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
01:29Acute Kidney Injury II: Pathophysiology
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
01:25Chronic Kidney Disease I: Introduction
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
01:24Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
01:28Chronic Kidney Disease III: Interprofessional Care
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...